Author:
Schmeichel Brooke E,Berridge Craig W
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference47 articles.
1. Arnsten AF (2009). Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs 23 (Suppl 1): 33–41.
2. Arnsten AFT, Castellanos FX (2002). Neurobiology of attention regulation and its disorders. In: Martin A, Scahill L, Charney D, Leckman J, (eds) Textbook of Child and Adolescent Psychopharmacology. Oxford University Press: New York. pp 99–109.
3. Berridge CW (2006). Neural substrates of psychostimulant-induced arousal. Neuropsychopharmacology 31: 2332–2340.
4. Berridge CW, Devilbiss DM (2011). Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder. Biol Psychiatry 69: e101–e111.
5. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B et al (2006). Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60: 1111–1120.
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献